November 1, 2022
Our Work
Latham & Watkins Advises Ligand Pharmaceuticals and OmniAb in Completion of Spin-Off and Business Combination
Multidisciplinary team advised on the deal which is one of the first Reverse Morris Trust (RMT) transactions combined with a deSPAC.